Anti-GALT8/ GALNT8/ GALNAC-T8 functional antibody

Anti-GALT8/ GALNT8/ GALNAC-T8 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GALNT8/GALNT8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0238-Ab-1/ GM-Tg-hg-SE0238-Ab-2Anti-Human GALNT8 monoclonal antibodyHuman
GM-Tg-rg-SE0238-Ab-1/ GM-Tg-rg-SE0238-Ab-2Anti-Rat GALNT8 monoclonal antibodyRat
GM-Tg-mg-SE0238-Ab-1/ GM-Tg-mg-SE0238-Ab-2Anti-Mouse GALNT8 monoclonal antibodyMouse
GM-Tg-cynog-SE0238-Ab-1/ GM-Tg-cynog-SE0238-Ab-2Anti-Cynomolgus/ Rhesus macaque GALNT8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0238-Ab-1/ GM-Tg-felg-SE0238-Ab-2Anti-Feline GALNT8 monoclonal antibodyFeline
GM-Tg-cang-SE0238-Ab-1/ GM-Tg-cang-SE0238-Ab-2Anti-Canine GALNT8 monoclonal antibodyCanine
GM-Tg-bovg-SE0238-Ab-1/ GM-Tg-bovg-SE0238-Ab-2Anti-Bovine GALNT8 monoclonal antibodyBovine
GM-Tg-equg-SE0238-Ab-1/ GM-Tg-equg-SE0238-Ab-2Anti-Equine GALNT8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0238-Ab-1/ GM-Tg-hg-SE0238-Ab-2; GM-Tg-rg-SE0238-Ab-1/ GM-Tg-rg-SE0238-Ab-2;
GM-Tg-mg-SE0238-Ab-1/ GM-Tg-mg-SE0238-Ab-2; GM-Tg-cynog-SE0238-Ab-1/ GM-Tg-cynog-SE0238-Ab-2;
GM-Tg-felg-SE0238-Ab-1/ GM-Tg-felg-SE0238-Ab-2; GM-Tg-cang-SE0238-Ab-1/ GM-Tg-cang-SE0238-Ab-2;
GM-Tg-bovg-SE0238-Ab-1/ GM-Tg-bovg-SE0238-Ab-2; GM-Tg-equg-SE0238-Ab-1/ GM-Tg-equg-SE0238-Ab-2
Products NameAnti-GALNT8 monoclonal antibody
Formatmab
Target NameGALNT8
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GALNT8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0238-Ag-1Recombinant multi-species GALT8/ GALNT8/ GALNAC-T8 protein


    Target information

    Target IDGM-SE0238
    Target NameGALNT8
    Gene ID26290,101056148,103690194,721912,486734,105260727,540652,100058625
    Gene Symbol and SynonymsGALNAC-T8,GALNT8,Gm29788
    Uniprot AccessionQ9NY28
    Uniprot Entry NameGALT8_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130035
    Target ClassificationN/A

    The target: GALNT8, gene name: GALNT8, also named as GALNAC-T8. This gene encodes a member of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes. GalNAc-Ts initiate mucin-type O-linked glycosylation in the Golgi apparatus by catalyzing the transfer of GalNAc to serine and threonine residues on target proteins. They are characterized by an N-terminal transmembrane domain, a stem region, a lumenal catalytic domain containing a GT1 motif and Gal/GalNAc transferase motif, and a C-terminal ricin/lectin-like domain. GalNAc-Ts have different, but overlapping, substrate specificities and patterns of expression. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.